MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...
Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation The trial met the primary safety ...
New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...
The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ...
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dr. Roach: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus ...
Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17. In late-breaking data presentations, the ADVANTAGE AF trial for the ...
Baptist Heart & Vascular Institute cardiologists, advanced practice providers and BHVI leadership recently gathered to celebrate the performance of its 1,000th Watchman procedure. The procedure is a ...
May is Stroke Awareness Month. 2 million brain cells die every minute a stroke goes untreated. Time is critical — and one major risk factor often goes unnoticed: Atrial Fibrillation (Afib). Afib is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback